# Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular Carcinoma

> **NCT01639352** · PHASE2 · COMPLETED · sponsor: **Lynn Feun** · enrollment: 20 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **BIOLOGICAL:** SOM230

## Key facts

- **NCT ID:** NCT01639352
- **Lead sponsor:** Lynn Feun
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2016-08
- **Final completion:** 2017-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01639352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01639352, "Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01639352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*